Unless I'm mistaken the current S.A. trial is being conducted with dronibinol. If the S.P.response to positive data with dronibinol is anything like what we got with the ampakine trials I don't see much value being created. I don't see the FDA approving any cannabinoid indications currently in trial due to it being in the same catagory as heroin. Not to mention that despite numerous trials over the last 30 years, the only way most doctors can prescribe it is if you are a patient with AIDS, or cancer undergoing chemo. The FDA has no problem with prescribing enough oxy and benzos to stop a Cape Buffalo in its tracks, so why go out on a limb with cannaboids, right?
Europe and Asia are a different story.
Re: taking it private. Jeff Margolis and Dr. Lippa certainly have the track record, contacts and resources to take CORX private, they've also been privy to information never revealed to shareholders (including the dreaded FDA letter formerly residing in Dr. Stoll's desk), so I have no doubt that if they believed it would be a profitable course of action, they'd have already embarked on a journey in that direction.
News 
Market Data 
Discover 
